TickerFacts.

Lipella Pharmaceuticals Inc. (LIPO): Operating Cash Flow

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$3.95M
Year ended 2024-12-31
-$4.78M
Trailing 12 months to 2025-09-30
2021-12-31: -$989.3K2022-12-31: -$1.83M2023-12-31: -$3.15M2024-12-31: -$3.95M-$3.95M
2021-12-31 Operating Cash Flow (USD) 2024-12-31
Period endedOperating Cash FlowChange YoYSource filing
2024-12-31-$3.95Mn/m2025-03-28, From 2024-01-01
2023-12-31-$3.15Mn/m2025-03-28, From 2023-01-01
2022-12-31-$1.83Mn/m2024-02-27, From 2022-01-01
2021-12-31-$989.3Kn/a2023-03-31, From 2021-01-01